Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Analogic Appoints Mark Laustra to Lead Rollout of New ConneCT Aviation Checkpoint Baggage Screening System

Posted on: 11 Oct 16

PEABODY, Mass., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced the appointment of Mark Laustra as vice president, global business development and government relations for its security business. Mark will lead the rollout of Analogic’s ConneCT™ Checkpoint Computed Tomography (CT) Screening System, the industry’s most advanced solution for the aviation checkpoint.

Photos accompanying this announcement are available at

Having more than 25 years of experience in aviation security, Mark brings deep knowledge of direct sales and government business development. He comes to Analogic from Astrophysics, a privately held manufacturer of X-ray screening systems, where he served as vice president, sales and government programs since 2013. Prior to that, Mark was vice president of homeland security at Smiths Detection, where he developed the company’s sales and marketing strategy for the US homeland security market. Mark currently serves as the chair of the Security Manufacturers Coalition, formed under the umbrella of the Airports Consultant Council (ACC), the voice for the industry in Washington, DC.

“We are excited to have Mark join our security and detection team at a time when Analogic is launching the world’s most advanced CT system for the checkpoint – the ConneCT,” said Jim Green, president and CEO. “This system is game-changing, and designed to deliver the highest level of threat detection for today and tomorrow, while dramatically reducing passenger wait times; all at a cost comparable to today’s 2-D X-ray systems.”

"CT is regarded as the next-generation passenger checkpoint detection system due to its ability to adapt to current and future threats,” said Mark Laustra. “Analogic is the sole manufacturer that can leverage its fundamental understanding of the demands of checked and passenger carry-on baggage screening applications and deliver a system that enables global governments to enhance aviation security. I am excited to be joining a great team at Analogic and helping shape the future of the industry.”

Green concluded, “With over 100 patents for CT and aviation security in the last decade alone – including nearly a dozen for screening at the checkpoint – Analogic’s ConneCT system combines our latest advancements in high-performance CT technology. Analogic is a trusted company with a proven track record of bringing unparalleled CT system reliability to the medical and aviation industries.”

The ConneCT is Analogic’s next-generation CT scanner, designed for the aviation security checkpoint. Analogic is currently preparing for U.S. and international certifications and expects to offer the system for sale in early 2017.

About Analogic
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Our market-leading ultrasound systems, led by our flagship BK Ultrasound brand, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical practitioners around the world. Our advanced imaging technologies are also used in computed tomography (CT), magnetic resonance imaging (MRI) and digital mammography systems, as well as automated threat detection systems for aviation security. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit

Analogic and the globe logo are registered trademarks of Analogic Corporation.


Last updated on: 12/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.